Enabling scalable final assembly for cartridge-based autoinjectors

In the July issue of ONdrugDelivery magazine, SHL Medical and SHL Advantec explore how flexible automation architecture and integrated final assembly services work together to enable seamless scalability for cartridge-based autoinjectors. Using the Reunite dual-chamber autoinjector and the Advantec Oval Unlimited (AOU) assembly machine platform as a case study, the article examines strategies for building resilient manufacturing operations from clinical validation through commercial launch and beyond. 

As combination products grow increasingly complex, manufacturers face pressure to accelerate speed-to-market while maintaining quality and adapting to changing commercial demand. For innovative drug-device projects, success depends not only on device performance but also on manufacturing infrastructure capable of supporting efficient commercialization and long-term scalability. 

The article discusses how SHL Medical integrates expertise in device development, SHL Advantec’s automation engineering, and SHL Medical Assembly and Services’ final assembly through a concurrent design for manufacturing and assembly (DFMA) approach from the early stages of development. By embedding manufacturing considerations into device development, we help safeguard clinical performance while providing greater flexibility to scale manufacturing as demand evolves. 

Read the full article to discover how SHL Medical’s integrated automation and final assembly capabilities enable the manufacturing agility and scalability needed to support innovative therapies from launch through long-term commercial growth.